Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 4 | 2011 | 2947 | 0.450 |
Why?
|
| Lung Neoplasms | 9 | 2011 | 11538 | 0.310 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 1823 | 0.210 |
Why?
|
| Cyclin D1 | 3 | 2011 | 576 | 0.170 |
Why?
|
| Cyclin E | 2 | 2009 | 267 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 3639 | 0.130 |
Why?
|
| Tetrahydronaphthalenes | 3 | 2011 | 116 | 0.120 |
Why?
|
| Mice | 9 | 2011 | 34495 | 0.090 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 88 | 0.090 |
Why?
|
| Anaphase | 1 | 2009 | 44 | 0.090 |
Why?
|
| Mice, Transgenic | 4 | 2011 | 4143 | 0.090 |
Why?
|
| Endopeptidases | 1 | 2010 | 220 | 0.090 |
Why?
|
| Anticarcinogenic Agents | 2 | 2008 | 362 | 0.090 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2008 | 50 | 0.080 |
Why?
|
| Ubiquitins | 1 | 2008 | 86 | 0.080 |
Why?
|
| Nicotinic Acids | 1 | 2008 | 33 | 0.080 |
Why?
|
| Lung | 2 | 2011 | 3151 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2009 | 249 | 0.080 |
Why?
|
| Tretinoin | 1 | 2010 | 623 | 0.080 |
Why?
|
| Oleanolic Acid | 1 | 2008 | 108 | 0.080 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2010 | 430 | 0.070 |
Why?
|
| Quinazolines | 2 | 2011 | 923 | 0.070 |
Why?
|
| ras Proteins | 1 | 2011 | 770 | 0.070 |
Why?
|
| Animals | 9 | 2011 | 59536 | 0.070 |
Why?
|
| Cyclins | 1 | 2007 | 456 | 0.070 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 755 | 0.070 |
Why?
|
| Cell Line, Tumor | 6 | 2010 | 14551 | 0.060 |
Why?
|
| Transgenes | 1 | 2007 | 557 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2011 | 886 | 0.060 |
Why?
|
| Transfection | 1 | 2009 | 2944 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 2508 | 0.060 |
Why?
|
| Computational Biology | 1 | 2010 | 1271 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 2488 | 0.050 |
Why?
|
| Biomarkers, Tumor | 2 | 2011 | 10331 | 0.050 |
Why?
|
| Cytokines | 1 | 2008 | 2809 | 0.040 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2011 | 388 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2010 | 8873 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 4757 | 0.040 |
Why?
|
| Humans | 9 | 2011 | 261506 | 0.030 |
Why?
|
| Drug Delivery Systems | 2 | 2009 | 669 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5319 | 0.030 |
Why?
|
| Prognosis | 1 | 2011 | 21713 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2008 | 2084 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2010 | 7226 | 0.030 |
Why?
|
| Mutation | 1 | 2011 | 15179 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 216 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 377 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 580 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2010 | 216 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2008 | 97 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1165 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 15862 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2008 | 85 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 7789 | 0.020 |
Why?
|
| Purines | 1 | 2009 | 273 | 0.020 |
Why?
|
| Cyclin G | 1 | 2007 | 10 | 0.020 |
Why?
|
| Cyclin G1 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 14289 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 666 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 837 | 0.020 |
Why?
|
| Taxoids | 1 | 2009 | 967 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 1408 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 589 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 1987 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1331 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2007 | 424 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 5395 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2011 | 2054 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2011 | 2295 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 3821 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2232 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 15193 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 2216 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 3254 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 4078 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12221 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 5178 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 5159 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 7591 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 10035 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 32848 | 0.010 |
Why?
|
| Female | 2 | 2011 | 141928 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 70117 | 0.000 |
Why?
|
| Middle Aged | 1 | 2011 | 86204 | 0.000 |
Why?
|
| Male | 1 | 2011 | 123000 | 0.000 |
Why?
|